Scientists have been trying to create a vaccine to treat cancer for decades, and with several clinical trials on their way, people will likely start having access to cancer vaccines by 2030. In this video, we explore the advances in our understanding of the immune system and new technologies that may produce the first successful therapeutic cancer vaccine in a couple of years. We discuss how the immune system detects cancer cells, the technological advances that have made it possible to identify targets specific to cancer cells, and the use of mRNA vaccines to boost the immune system's response to eliminate cancer cells. We also explore the role of Artificial Intelligence in personalized medicine and its potential in treating aggressive cancers. Discover the promise of cancer treatment with therapeutic cancer vaccines.
Easy Read:
[ Ссылка ]
Sources:
Cancer vaccines: antigen selection strategy.
[ Ссылка ]
MHC-I Genotype Restricts the Oncogenic Mutational Landscape
[ Ссылка ]
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
[ Ссылка ]
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
[ Ссылка ]
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
[ Ссылка ]
Bioinformatics for Cancer Immunotherapy
[ Ссылка ]
Timestamp
00:00 - Intro
00:15 - Immune System and Cancer
01:20 - Cancer Evasion System
02:17 - Genetic Sequencing and Neoantigens
03:30 - Personalized mRNA vaccines
04:19 - A.I.
04:46 - Putting all together
